KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Non Operating Income (2016 - 2025)

Pacific Biosciences Of California (PACB) has 16 years of Non Operating Income data on record, last reported at $2.8 million in Q4 2025.

  • For Q4 2025, Non Operating Income fell 31.91% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $14.8 million, down 37.95%, while the annual FY2025 figure was $14.8 million, 37.95% down from the prior year.
  • Non Operating Income reached $2.8 million in Q4 2025 per PACB's latest filing, down from $3.0 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $8.9 million in Q2 2023 and bottomed at -$279000.0 in Q1 2022.
  • Average Non Operating Income over 5 years is $3.9 million, with a median of $4.2 million recorded in 2024.
  • The widest YoY moves for Non Operating Income: up 634700.0% in 2022, down 535.94% in 2022.
  • A 5-year view of Non Operating Income shows it stood at $1000.0 in 2021, then soared by 634700.0% to $6.3 million in 2022, then soared by 32.06% to $8.4 million in 2023, then crashed by 51.51% to $4.1 million in 2024, then plummeted by 31.91% to $2.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $2.8 million in Q4 2025, $3.0 million in Q3 2025, and $4.7 million in Q2 2025.